Related Experiment Video
Updated: Sep 16, 2025
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Interactions between Covid-19 and chronic disease: A multilevel analysis of treatment strategies and outcomes
Yerzhan Zhunussov1, Yevgeniya Li1, Bakhyt Kosherova2
1KARAGANDA MEDICAL UNIVERSITY, KARAGANDA, KAZAKHSTAN.
Insights
Chronic diseases significantly impact COVID-19 severity and outcomes. Personalized treatment strategies considering comorbidities are crucial for optimizing patient care and improving recovery from coronavirus disease 2019.
Area of Science:
- Infectious Diseases
- Internal Medicine
- Clinical Research
Background:
- Chronic diseases like hypertension and diabetes are prevalent globally.
- COVID-19 (coronavirus disease 2019) disproportionately affects individuals with comorbidities.
- Understanding the interplay between chronic conditions and viral infections is critical for public health.
Purpose of the Study:
- To analyze the interaction between COVID-19 and various chronic diseases.
- To evaluate the effectiveness of different treatment strategies in COVID-19 patients with comorbidities.
- To identify factors influencing therapy outcomes in a cohort of 236 patients.
Main Methods:
- Retrospective analysis of 236 COVID-19 patients at a regional clinical hospital.
- Assessment of laboratory indicators and their correlation with chronic conditions (diabetes, hypertension, cardiovascular, respiratory, cancer).
- Consideration of demographic data (age, gender) and hospitalization duration.
Main Results:
- No significant age difference observed between moderate and severe COVID-19 cases (mean age 66 years).
- Severe COVID-19 cases had longer hospitalization (15 days vs. 11 days, p<0.001) and higher mortality, particularly with multiple comorbidities.
- Arterial hypertension and coronary artery disease were common; their impact on outcomes varied, with some treatments showing differential effectiveness.
Conclusions:
- Chronic diseases critically influence COVID-19 severity and patient outcomes.
- Personalized, multidisciplinary treatment approaches are essential for managing COVID-19 in patients with comorbidities.
- Tailoring therapies based on individual comorbidity profiles can optimize clinical results and reduce mortality.
Objective:
Aim: The purpose of study was to analyse the interaction between COVID-19 and chronic diseases, with a focus on evaluating the effectiveness of treatment strategies.
Patients And Methods:
Materials and Methods: The study, conducted at the Infectious Disease Centre of the Regional Clinical Hospital of Karaganda, aimed to determine factors influencing therapy effectiveness in 236 COVID-19 patients. It assessed the dynamics of laboratory indicators and their relationship with chronic diseases like diabetes, hypertension, cardiovascular conditions, chronic respiratory diseases, and cancer. Demographic data, including age and gender, were also considered.
Results:
Results: The study revealed no significant age difference between patients with moderate and severe COVID-19 courses, with both groups averaging a similar age of 66 years. The duration of hospitalization was significantly longer for patients with severe disease, who required an average of 15 days, compared to 11 days for patients with moderate disease (p<0.001). Comorbidities, especially arterial hypertension and coronary artery disease, were common in patients with moderate disease but had less impact on outcomes compared to severe cases, where multiple chronic conditions were linked to higher mortality. Some treatments had a more pronounced effect in this group of patients, while others may have been less effective or had negative effects.
Conclusion:
Conclusions: The study highlights the critical impact of chronic diseases on the severity and outcomes of COVID-19, emphasizing the need for personalized, multidisciplinary treatment strategies that consider comorbidities to optimize patient outcomes.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:28Chronic Kidney Disease III: Interprofessional Care
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:21Rheumatic Heart Disease III: Medical Management